BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7447583)

  • 1. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Slower lidocaine elimination and dose adjustment in patients with heart failure].
    Follath F; Ritz R; Vozeh S; Wenk M
    Schweiz Med Wochenschr; 1982 May; 112(22):789-91. PubMed ID: 6808662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
    Davison R; Parker M; Atkinson AJ
    Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple method for maintaining serum lidocaine levels in the therapeutic range.
    Wong BY; Hurwitz A
    Arch Intern Med; 1985 Sep; 145(9):1588-91. PubMed ID: 4026487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
    Oltmanns D; Siegers CP
    Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma level of lidocaine following intraoperative bolus injection and infusion in heart failure].
    Biscoping J; von Bormann B; Boldt J; Kling D; Hempelmann G
    Anasth Intensivther Notfallmed; 1984 Oct; 19(5):250-2. PubMed ID: 6335002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of congestive heart failure on blood vessels of lidocaine and its active monodeethylated metabolite.
    Halkin H; Meffin P; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1975 Jun; 17(6):669-76. PubMed ID: 1139858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.
    LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A
    Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
    Kettner W; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
    Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
    Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.